Cooperative Ovarian Cancer Group

The Cooperative Ovarian Cancer Group (COGI), based at Stanford University, is a consortium of ovarian cancer researchers from leading academic medical centers throughout the United States. This group was formed in 2004 to focus on the development of vaccines and innovative immunotherapies for ovarian cancer.

Since its inception, COGI has supported laboratory and clinical programs to develop immunotherapies for ovarian cancer. We are part of the international consortium of coopertive clinical trials group for gynecologic malignancies, the Gynecologic Cancer Inter Group (GCIG).

Stanford University COGI Contacts

Jonathan Berek, M.D., M.M.S.

Primary Investigator, COGI
Stanford University

Oliver Dorigo, M.D., Ph.D.

Co-Primary Investigator, COGI
Stanford University

Ashley Powell, Ph.D.

Research Coordinator, COGI
Stanford University

Stanfordwho Profile

OVERALL STRATEGY

  • Develop a strong Core Program that coordinates a network of clinical investigators
  • Support and facilitate basic laboratory investigations
  • Create partnerships with biotech industry that will support and utilize our group
  • Recruit additional funding to expand our programs 

Quick Links